Despite the availability of vaccines and therapeutics, continual genetic alterations render the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) a persistent threat …
MM Castellanos, H Gressard, X Li, C Magagnoli… - Vaccines, 2023 - mdpi.com
This review reports on an overview of key enablers of acceleration/pandemic and preparedness, covering CMC strategies as well as technical innovations in vaccine …
Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options has been studied and deployed. Healthcare providers have multiple treatment approaches …
M Liu, Z Liang, ZJ Cheng, L Liu, Q Liu… - Reviews in Medical …, 2023 - Wiley Online Library
The COVID‐19 pandemic represents an unparalleled global public health crisis. Despite concerted research endeavours, the repertoire of effective treatment options remains limited …
Monoclonal antibodies (mAbs) administered intranasally as dry powders can be potentially applied for the treatment or pre-exposure prevention of viral infections in the upper …
GC Barnard, M Zhou, A Shen, IH Yuk… - Biotechnology …, 2024 - Wiley Online Library
Monoclonal antibodies (mAbs) are effective therapeutic agents against many acute infectious diseases including COVID‐19, Ebola, RSV, Clostridium difficile, and Anthrax …
H Broly, J Souquet, A Beck - MAbs, 2023 - Taylor & Francis
The COVID-19 pandemic highlighted the urgent need for life-saving treatments, including vaccines, drugs, and therapeutic antibodies, delivered at unprecedented speed. During this …
Y Nishida, K Kodama, S Sengoku - Drug Discovery Today, 2023 - Elsevier
Highlights•Gene therapy is becoming established in the treatment of rare diseases.•The ease of starting clinical development has attracted startups, including those from academia.• …
AT Muurmann, M Banovic, MTP Gilbert, G Sogari… - Food Research …, 2024 - Elsevier
One third of the food produced for human consumption is currently lost or wasted. Insects have a high potential for converting organic waste-and by-products into food and feed for a …